Register now for free webinar on Canadian private insurance

Title: Navigating Private Insurance in Canada Date and time: November 30, 2017 from 1pm-2pm ET Register now! Canadians are often uncertain about the role and limits of their private insurance coverage. Let’s change that. For this webinar, we’re joined by Suzanne Lepage, private health plan specialist, for a discussion of Canada’s private drug plan marketplace

CCSN hosts Legislative Reception on cancer-associated thrombosis

The Canadian Cancer Survivor Network (CCSN) held their annual Legislative Reception at  Queen’s Park On October 26, 2017. The Reception was an opportunity for patients, MPPs and doctors to discuss cancer-associated thrombosis (CAT), and, despite the ongoing election-prep furor in the Ontario Legislature, the turn out to the event surpassed that of previous years. Over 30

#GivingTuesday is November 28!

It’s time to get excited for #GivingTuesday! The day is a chance for caring individuals to show their support for charities across the North America. It is the biggest single fundraising day next to New Year’s Eve, and it makes so many incredible initiatives possible.

Watch: Clinical Trials 101

This webinar will tell you what you need to know about clinical trials, their history, and help you prepare for a trial. If you’re currently considering participating in a clinical trial, we hope that this webinar helps to answer many of your questions. In the presentation you’ll learn the difference between different types of clinical

Jackie Manthorne Recognised with Jack Shapiro Lifetime Achievement Award

Ottawa, ON – Jackie Manthorne, President and CEO of the Canadian Cancer Survivor Network (CCSN), has spent over twenty years giving a voice to cancer patients, survivors and caregivers. This fall, that dedication was recognised by the Canadian Cancer Action Network (CCAN), which awarded Manthorne the 2017 Jack Shapiro Lifetime Achievement Award at their Annual

Watch: Webinar on biosimilars

Biologic cancer treatments have become incredibly important in oncology, but they can be expensive. Biosimilars are molecules manufactured to replicate the effects of biologics. They give patients and providers a choice and help to drive prices down through competition, but doctors, patients and caregivers need to understand what biosimilars are, what they can do, and

Watch our webinar titled “Cancer Associated Blood Clots”

This webinar introduces you to the effects of blood clots on cancer patients. This webinar also provides you with the following information: How and why blood clots effect cancer patients more than the general population Diagnosis and treatment options Resources for more information The presentation is followed by an interactive discussion with participants. Presenter Information Dr.

Avelumab Survey

The purpose of this survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about the use of Avelumab for the treatment of patients with Merkel cell carcinoma. The survey will be open until Oct. 20. The results of our survey are to be submitted in our patient evidence study to the

Have you experienced a blood clot during cancer treatment?

If you or a loved one has experienced a blood clot after you were diagnosed with cancer or during chemotherapy, you live in Ontario and would like to help CCSN raise awareness about it, please get in touch with CCSN president & CEO Jackie Manthorne at jmanthorne@survivornet.ca. Every year there are 30,000 incidences of cancer-associated

Cancer Patients Celebrate New Program for Take-Home Cancer Medications in Nova Scotia

Halifax, Nova Scotia, September 27, 2017 – The CanCertainty Coalition, the united voice of 35 Canadian cancer organizations, applauds the McNeil Government’s decision to address the funding gap for take-home cancer medications and eliminate much of the financial hardship and related stress that patients in the province face, as announced in Tuesday’s budget. “This is